This study aimed to utilize ultrasound elastography imaging to measure the changes in liver stiffness after TGF-β1 signaling pathway-targeted combination therapy for hepatic fibrosis so as to determine if this technique can be used as a non-invasive method for monitoring the effects of anti-fibrosis therapy. Here, TGFB1 is linked to Hepatic fibrosis.